rheumatoid arthritis

Pfizer Says Primary Goal Met in Tofacitinib Trial
Bloomberg
Fri, 03/4/11 - 10:34 am
Pfizer
rheumatoid arthritis
tofacitinib
Bristol-Myers Squibb: Outstanding Pipeline Makes It Most Attractive Among Large Pharmaceuticals
Seeking Alpha
Fri, 02/25/11 - 12:06 am
pipelines
Bristol-Myers Squibb
Reyataz
HIV
Baraclude
Orencia
rheumatoid arthritis
Sprycel
chronic myeloid leukemia
Onglyza
diabetes
hepatitis B
Pfizer & Takeda enter co-promotion agreements for rheumatoid arthritis products in Japan
pharmabiz
Sat, 02/5/11 - 11:47 am
Pfizer
Takeda
Enbrel
tasocitinib
CP-690
550
rheumatoid arthritis
Are Merck And J&J Fighting Over A Shrinking Pie?
Pharmalot
Thu, 01/27/11 - 11:29 am
Merck
JNJ
Simponi
rheumatoid arthritis
Remicade
Antares Pharma to Initiate Clinical Trial of VIBEX™ MTX in First Quarter of 2011
Wed, 01/12/11 - 04:26 pm
Antares Pharma
VIBEX
rheumatoid arthritis
injectables
Novartis plans trial of equivalent to Roche drug
Marketwatch
Mon, 01/10/11 - 12:16 pm
Roche
Novartis
biosimilars
Rituxan
Sandoz
rheumatoid arthritis
rituximab
CELTIC THERAPEUTICS AND BELLUS HEALTH INITIATE CONFIRMATORY PHASE III CLINICAL STUDY FOR KIACTA
PR-Canada.net
Sat, 12/18/10 - 01:55 pm
Celtic Therapeutics
Bellus Health
Kiacta
AA amyloidosis
rheumatoid arthritis
Lexicon Pharmaceuticals Shares Plunged: What You Need to Know
Motley Fool
Wed, 12/15/10 - 10:31 am
Lexicon Pharmaceuticals
rheumatoid arthritis
LX2931
Portola Pharmaceuticals Announces Data Presentations Highlighting Syk/JAK Inhibitor Clinical Development Program at 52nd American Society of Hematology Annual Meeting
Sun Herald, MS
Sun, 12/5/10 - 12:16 pm
Portola Pharmaceuticals
non-Hodgkin's lymphoma
chronic lymphocytic leukemia
rheumatoid arthritis
JAK inhibitors
Syk inhibitors
Pfizer, Incyte and Eli Lilly drug developments could transform future of rheumatoid arthritis therapy
FT.com
Mon, 11/29/10 - 12:44 pm
rheumatoid arthritis
Pfizer
Incyte
Eli Lilly
Rigel
JAK inhibitors
fostamatinib
UCB Falls Most in Six Months as UBS Downgrades, Says Takeover Is Unlikely
Bloomberg
Mon, 11/15/10 - 10:38 am
UCB Pharmaceuticals
M&A
Cimzia
Pfizer
rheumatoid arthritis
The Top 10 Phase III Failures of 2010
Fierce Biotech
Fri, 10/22/10 - 11:36 am
clinical trials
dimebon
Medivation
Pfizer
ocrelizumab
Roche
rheumatoid arthritis
taspoglutide
diabetes
Ipsen
semagacestat
Eli Lilly
ASA404
Antisoma
Novartis
Novelos Therapeutics
AstraZeneca
zibotentan
vicriviroc
Merck
Recentin
Vical
Sanofi
Rigel Pharma earns $25M AstraZeneca payment tied to potential rheumatoid arthritis treatment
Yahoo/AP
Wed, 09/29/10 - 10:49 am
Rigel
AstraZeneca
milestone payments
rheumatoid arthritis
fostamatinib
Centocor seeks expansion of Simponi use
Bizjournals.com
Mon, 09/27/10 - 12:19 pm
Janssen Biotech
Simponi
rheumatoid arthritis
AZ/Rigel RA drug hits PhIIb paydirt
Fierce Biotech
Thu, 09/23/10 - 09:45 am
Rigel
rheumatoid arthritis
AstraZeneca
Basque consortium develops a microsensor monitoring arthritis and psoriasis
Fri, 07/9/10 - 01:42 pm
CIC microGUNE
BioDonostia Institute
Proteomika
Abyntek
Progenika Group
rheumatoid arthritis
Crohn's Disease
ulcerative colitis or psoriasis
Bristol-Myers' Orencia gets expanded use in Europe
Yahoo/AP
Wed, 07/7/10 - 12:15 pm
Bristol-Myers Squibb
Orencia
Europe
rheumatoid arthritis
Chelsea Therapeutics says it will submit new rheumatoid arthritis drug data to FDA in July
Yahoo/AP
Tue, 06/29/10 - 09:51 am
Chelsea Therapeutics
rheumatoid arthritis
FDA
Out-of-Pocket Costs Put Arthritis Drugs Out Of Reach For Some
Medical News Today
Sun, 05/23/10 - 11:57 am
arthritis
rheumatoid arthritis
A Potential Blockbuster Bites the Dust. Should You Worry?
Motley Fool
Wed, 05/19/10 - 06:08 pm
Biogen Idec
ocrelizumab
Roche
rheumatoid arthritis

Pages